Related Experiment Video
Updated: Jun 23, 2026

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
Published on: November 10, 2023
Treatment options for malignant pleural effusion
1Division of Pulmonary, Allergy and Critical Care Medicine, National Jewish Health, 1400 Jackson Street, J225, Denver, CO 80206, USA. musania@njhealth.org
Purpose Of Review:
Thirty percent of lung cancers eventually result in malignant pleural effusion (MPE). Devastating consequences of MPE, such as dyspnea and cough, severely deteriorate the quality of life of these patients. Malignant pleural effusion portends a dismal prognosis of less than 6-month longevity, with the exception of breast and ovarian cancer. Given the poor prognosis of the majority of these patients, palliation, rather than cure, should be the goal of therapy.
Recent Findings:
Chest tube insertion and sclerotherapy remain the standard of care. Emerging therapeutic options such as medical pleuroscopy and indwelling pleural catheters offer cost-effective and outpatient treatments for MPE.
Summary:
In the following review, the medical, economic, and social aspects of different current options for the management of MPE are discussed.
Insights
Malignant pleural effusion (MPE) significantly impacts lung cancer patients, often requiring palliative care due to poor prognosis. Newer treatments like medical pleuroscopy and indwelling pleural catheters offer promising outpatient management options.
Area of Science:
- Pulmonology
- Oncology
- Palliative Care
Background:
- Malignant pleural effusion (MPE) affects 30% of lung cancer patients.
- MPE severely impacts quality of life due to symptoms like dyspnea and cough.
- Prognosis is generally poor, with a median survival under six months, except for breast and ovarian cancers.
Purpose of the Study:
- To review current management options for MPE.
- To discuss the medical, economic, and social aspects of MPE treatments.
- To highlight the shift towards palliative care over curative intent for most MPE patients.
Main Methods:
- Review of existing literature on MPE management.
- Analysis of established and emerging therapeutic strategies.
- Evaluation of treatment outcomes and patient-centered factors.
Main Results:
- Chest tube insertion and sclerotherapy are current standards of care for MPE.
- Emerging options include medical pleuroscopy and indwelling pleural catheters.
- These newer methods offer cost-effective, outpatient management for MPE.
Conclusions:
- Management of MPE should prioritize palliation due to the generally poor prognosis.
- Medical pleuroscopy and indwelling pleural catheters represent advancements in MPE treatment.
- Further evaluation of medical, economic, and social impacts of MPE management is warranted.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pleural Disorders: Types and Brief Description
Pneumothorax-II
Clinical Manifestations:

